A comprehensive Ayurvedic treatment along with counseling in oligoasthenozoospermia with previous intrauterine insemination failure-A case report. | LitMetric
Department of Stri Roga and Prasuti Tantra (Gynaecology& Obstetrics), Amrita School of Ayurveda, Amritapuri, Amrita Vishwa Vidyapeetham, India. Electronic address:
Published: July 2020
AI Article Synopsis
Article Abstract
Male infertility contributes for 50% of infertility globally, and several etiological factors contribute to it. Oligoasthenozoospermia and anxiety, forms a vicious cycle, resulting in male infertility. A man advised for assisted reproductive techniques, even after correcting seminal parameters has poor success rate if the symptoms of anxiety is left untreated. The signs and symptoms of oligoasthenozoospermia can be compared with Kshina shukra of Ayurvedic classics. The present case report presents, the role of an indigenous combination of drugs in improving the quantity and quality of semen, along with the reduction in anxiety levels through counseling. The patient with low sperm motility and volume was subjected to Ayurvedic management protocol of initially Counseling, followed by Shodhana treatment and then administration of Mashadi choornam for 90 days. A marked improvement was observed in seminal parameters and anxiety levels and patient could undergo natural conception, a few months after the treatment, thus focusing on an integrative approach.
Purpose: This study aimed to investigate the genetic etiology in an infertile patient presenting with consistently elevated progesterone levels.
Methods: Genomic DNA was extracted from the patient's blood sample and subjected to whole-genome sequencing (NGS) using the Illumina NovaSeq platform. Bioinformatic analyses were conducted to identify single nucleotide variants (SNVs) and insertion-deletion mutations (Indels) potentially associated with the patient's clinical phenotype.
Background: NeoDura (Medprin Biotech Gmbh) is an absorbable dural repair patch consisting of degradable poly-L-lactic acid and porcine gelatin that provides a hermetic closure of the dura mater (Medprin Biotech. Neodura. Dural Repair Patch [Brochure].
Background: Concurrent ST-elevation myocardial infarction (STEMI) and acute ischemic stroke (AIS) are extremely rare, and their management remains perplexing due to the absence of high-quality evidence and limited resources. For the first time, we report a rare, preventable, and suboptimally managed case of concurrent AIS and STEMI in a patient with non-Hodgkin lymphoma (NHL) who received cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) chemotherapy.
Case Presentation: A 59-year-old postmenopausal woman of African origin with a background history of type 2 diabetes mellitus presented to the Jakaya Kikwete Cardiac Institute with sudden onset of left-sided weakness and typical ischemic chest pain for 3 days.
Background: Thrombotic microangiopathy (TMA) is a rare, life-threatening disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end-organ damage. Atypical hemolytic uremic syndrome (aHUS) is even less common, comprising less than 10% of hemolytic uremic syndrome (HUS) cases. aHUS in postpartum is associated with poor maternal outcomes, with the majority of cases resulting in end-stage renal disease.
